WILMINGTON, N.C., May 8, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing products to treat ...
WILMINGTON, N.C., May 2, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the Bank of America Merrill Lynch 2012 Health Care Conference in Las Vegas, NV on Wednesday, May 16, 20...
WILMINGTON, N.C., April 25, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release first quarter 2012 financial and operating results after market close on Tuesday, May 8, 2012. Ken Reali, President and Chief Executive Officer of TranS1, and Joe Slattery, Chief Financial Officer, will host a conference call star...
WILMINGTON, N.C., April 5, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing spine products to treat degenerative conditions of the spine affecting the lower lumbar region, announced today that it has appointed Jeffrey Fischgrund, M.D. to serve on its Board of Directors. Dr. ...
- Fourth quarter revenues were $4.0 million -- 310 TranS1 procedures performed globally in the quarter -- Launch of VEOTM Lateral Access and Interbody Fusion System - - Net loss per share was $0.18 for the quarter -- Category I CPT code application approved -
WILMINGTON, N.C., March 8, 2012 (GLOBE NEWSWIRE) --TranS1 Inc. (Nasdaq:TSON), a medic...
WILMINGTON, N.C., March 5, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat degenerative conditions of the spine affecting the lower lumbar region, announced today that the American Medical Association ("AMA") Current Procedural Ter...
WILMINGTON, N.C., Feb. 24, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designing, developing and marketing minimally invasive spine products to treat degenerative conditions of the spine affecting the lower lumbar region, announced today the opening of its new training center in Raleigh, NC. In conjunctio...
WILMINGTON, N.C., Feb. 23, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release fourth quarter 2011 financial and operating results after market close on Thursday, March 8, 2012. Ken Reali, President and Chief Executive Officer of TranS1, and Joe Slattery, Chief Financial Officer, will host a conference call s...
WILMINGTON, N.C., Feb. 16, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Joe Slattery, Executive Vice President and Chief Financial Officer, will participate in the LCM 4rd Annual Medical Technology Snowbird Event on Thursday, March 1, 2012 at the Snowbird Ski and Summer Resort in Snowbird, UT.
The conference format co...
WILMINGTON, N.C., Jan. 26, 2012 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the Canaccord Genuity Musculoskeletal Conference in San Francisco, CA on Tuesday, February 7, 2012 at...
WILMINGTON, N.C., Dec. 14, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced that Palmetto GBA ("Palmetto"), a Medicare Administrative Contractor, has removed its Non-Coverage policy for AxiaLIF effective January 1, 2012.
In its letter, Palmetto indicated that...
WILMINGTON, N.C., Nov. 17, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Stephen Ainsworth, PhD, Vice President of Research and Development, are scheduled to present at the 23rd Annual Piper Jaffray Healthcare Conference in New York City, on November 29, 2011 at 1:30 p....
WILMINGTON, N.C., Nov. 16, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a pioneer in minimally invasive approaches to lumbar spine surgery, today announced the launch of its new lateral access fusion system for interbody fusions.
TranS1's minimally invasive lateral system features an innovative, two-stage retraction method that focuses o...
WILMINGTON, N.C., Nov. 3, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the Lazard Capital Markets 8th Annual Healthcare Conference in New York, NY, November 16, 2011 at 10:3...
-- Third quarter revenues were $4.7 million ---- 387 TranS1 procedures performed globally in the quarter --
-- Net loss per share was $0.16 for the quarter --
-- $18.3 million net cash raised in stock offering --
WILMINGTON, N.C., Nov. 1, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON), a medical device company focused on designin...
WILMINGTON, N.C., Oct. 20, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that it plans to release third quarter 2011 financial and operating results after market close on Tuesday, November 1, 2011. Ken Reali, President and Chief Executive Officer of TranS1 and Joe Slattery, Chief Financial Officer, will host a conference call s...
WILMINGTON, N.C., Sept. 26, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) today announced that it closed its previously announced public offering of 6,200,000 shares of its common stock at a price to the public of $3.25 per share. The net proceeds to TranS1 from the sale of shares, after taking into account estimated offering expenses, are app...
WILMINGTON, N.C., Sept. 21, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) today announced that it has priced its public offering of 6,200,000 shares of its common stock at a price to the public of $3.25 per share. TranS1 has granted the underwriters a 30-day option to purchase up to 930,000 additional shares of common stock to cover over-allot...
WILMINGTON, N.C., Sept. 20, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) today announced that it intends to offer shares of its common stock in a public offering. Piper Jaffray & Co. is acting as the sole book-running manager for the offering and Canaccord Genuity is acting as co-manager.
A shelf registration statement relating to the sha...
WILMINGTON, N.C., Aug. 23, 2011 (GLOBE NEWSWIRE) -- TranS1 Inc. (Nasdaq:TSON) announced today that Ken Reali, President and Chief Executive Officer, and Joe Slattery, Executive Vice President and Chief Financial Officer, are scheduled to present at the 2011 Stifel Nicolaus Healthcare Conference in Boston, MA on Wednesday, September 7, 2011 at 2:40 ...
